Stockreport

Health Canada Accepts for Review New Drug Submission for Tofersen for Treatment of Rare, Genetic Form of ALS [Yahoo! Finance]

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com
PDF Health Canada regulatory decision on tofersen New Drug Submission expected in early 2025 TORONTO March 19, 2024 /CNW/ - Biogen Canada Inc. announced today that Health [Read more]